— Know what they know.
Not Investment Advice

PBIO OTC

Pressure BioSciences, Inc.
1W: +0.0% 1M: -50.0% 3M: -71.4% YTD: -60.0% 1Y: -60.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Neutral · Power 46 · $8193 mcap · 41M float · 0.011% daily turnover · Short 97% of daily vol

Balance Sheet Trends

Total Assets
$1M -47.8% ▼
5Y CAGR: -15.2%
Total Liabilities
$34M -2.6% ▼
5Y CAGR: +31.7%
Shareholders Equity
-$33M -0.2% ▼
Cash & Investments
$81K +2002.9% ▲
5Y CAGR: -4.6%
Total Debt
$23M +11.5% ▲
5Y CAGR: +35.5%
Net Debt
$23M +11.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$30K$19K$132K$4K$81K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$30K$19K$132K$4K$81K
Net Receivables$229K$131K$155K$295K$151K
Inventory$618K$593K$1M$686K$305K
Other Current Assets$0$0$0$258K$0
Total Current Assets$1M$1M$2M$1M$760K
Property, Plant & Equip.$132K$238K$511K$385K$228K
Goodwill & Intangibles$577K$490K$404K$317K$0
Long-Term Investments$17K$517K$60K$64K$62K
Other Non-Current Assets$0$0-$975K$64M$0
Total Non-Current Assets$726K$1M$975K$766K$290K
Total Assets$2M$2M$3M$2M$1M
— Liabilities —
Accounts Payable$816K$772K$528K$637K$1M
Short-Term Debt$8M$9M$14M$20M$23M
Deferred Revenue$23K$47K$37K$58K$234K
Other Current Liabilities$5M$8M$10M$13M$9M
Total Current Liabilities$14M$19M$25M$34M$34M
Long-Term Debt$0$527K$150K$150K$162K
Other Non-Current Liab.$0$19K$0$0$0
Total Non-Current Liabilities$18K$703K$416K$292K$227K
Total Liabilities$14M$19M$25M$35M$34M
— Equity —
Common Stock$25K$42K$91K$137K$354K
Retained Earnings-$79M-$96M-$118M-$134M-$169M
Accumulated OCI$23M$29M$32M$32M$36M
Total Stockholders Equity-$12M-$17M-$22M-$33M-$33M
Total Liabilities & Equity$2M$2M$3M$2M$1M
— Key Metrics —
Total Debt$8M$10M$15M$21M$23M
Net Debt$8M$10M$15M$21M$23M
Total Investments$17K$517K$60K$64K$62K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms